Gemcitabine: Metabolism, mechanisms of action, and self-potentiation

Seminars in Oncology

Volumn 22, Issue 4 SUPPL. 11, 1995, Pages 3-10

  Plunkett, W ^a   Huang, P ^a   Xu, Y Z ^a   Heinemann, V ^a   Grunewald, R ^a   Gandhi, V ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEOXYCYTIDINE KINASE; DNA POLYMERASE; GEMCITABINE; PRODRUG;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; CELL DEATH; CHO CELL; CONFERENCE PAPER; DRUG DESIGN; DRUG MECHANISM; DRUG METABOLISM; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; SOLID TUMOR;

ANIMAL; ANTIMETABOLITES, ANTINEOPLASTIC; CELL DEATH; CYTIDINE DEAMINASE; DEOXYCYTIDINE; DNA, NEOPLASM; DRUG SYNERGISM; HALF-LIFE; HUMAN; PRODRUGS; RIBONUCLEOTIDE REDUCTASES; SUBSTRATE SPECIFICITY; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TUMOR CELLS, CULTURED;

EID: 0028799108     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (0)